Gastrointestinal cancer specialist joins Henry Ford Cancer Institute
Philip A. Philip, MD, PhD, has been appointed director of gastrointestinal oncology and neuroendocrine oncology at Henry Ford Cancer Institute.
Philip also will serve as medical director of research and clinical care integration, and co-leader of Henry Ford Pancreatic Cancer Center.
“Dr. Philip is a prolific researcher and skillful clinician with extensive experience in an academic medical center environment,” Steven Kalkanis, MD, CEO of Henry Ford Medical Group and chief academic officer at Henry Ford Health System, said in a press release. “He is a strong leader with a proven track record demonstrating his deep commitment to providing outstanding patient care and achieving scientific breakthroughs that are continuing to help advance research in many aspects of pancreatic cancer.”
Philip, recognized for his expertise in pancreatic cancer and neuroendocrine tumors, held several leadership roles at Karmanos Cancer Center over the past 25 years.
He will continue to serve as tenured professor of oncology at Wayne State University School of Medicine.
“Dr. Philip’s wide-ranging expertise on both the national and international cancer research stages will be an invaluable addition to our Henry Ford Cancer Institute as we continue to pursue discoveries that will increase survivorship among patients with pancreatic cancer,” Benjamin Movsas, MD, interim medical director of Henry Ford Cancer Institute, said in the release. “By leveraging our advanced research and clinical capabilities, we remain committed to reducing disparities in cancer outcomes and staying on the forefront of scientific research that will help save lives.”